Your browser doesn't support javascript.
loading
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.
Sherman, Mara H; Yu, Ruth T; Engle, Dannielle D; Ding, Ning; Atkins, Annette R; Tiriac, Herve; Collisson, Eric A; Connor, Frances; Van Dyke, Terry; Kozlov, Serguei; Martin, Philip; Tseng, Tiffany W; Dawson, David W; Donahue, Timothy R; Masamune, Atsushi; Shimosegawa, Tooru; Apte, Minoti V; Wilson, Jeremy S; Ng, Beverly; Lau, Sue Lynn; Gunton, Jenny E; Wahl, Geoffrey M; Hunter, Tony; Drebin, Jeffrey A; O'Dwyer, Peter J; Liddle, Christopher; Tuveson, David A; Downes, Michael; Evans, Ronald M.
Afiliación
  • Sherman MH; Gene Expression Laboratory, Salk Institute, La Jolla, CA 92037, USA.
  • Yu RT; Gene Expression Laboratory, Salk Institute, La Jolla, CA 92037, USA.
  • Engle DD; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
  • Ding N; Gene Expression Laboratory, Salk Institute, La Jolla, CA 92037, USA.
  • Atkins AR; Gene Expression Laboratory, Salk Institute, La Jolla, CA 92037, USA.
  • Tiriac H; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
  • Collisson EA; Department of Medicine/Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143, USA.
  • Connor F; Cancer Research UK Cambridge Research Institute, The Li Ka Shing Centre, Robinson Way, Cambridge CB2 ORE, UK.
  • Van Dyke T; Center for Advanced Preclinical Research, NCI-Frederick, Frederick, MD 21702, USA.
  • Kozlov S; Center for Advanced Preclinical Research, Leidos Biomed, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Martin P; Center for Advanced Preclinical Research, Leidos Biomed, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Tseng TW; Gene Expression Laboratory, Salk Institute, La Jolla, CA 92037, USA.
  • Dawson DW; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Donahue TR; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Masamune A; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai Miyagi, 980-8574, Japan.
  • Shimosegawa T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai Miyagi, 980-8574, Japan.
  • Apte MV; Pancreatic Research Group, Faculty of Medicine, South Western Sydney Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
  • Wilson JS; Pancreatic Research Group, Faculty of Medicine, South Western Sydney Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
  • Ng B; Diabetes and Transcription Factors Group, Garvan Institute of Medical Research (GIMR), Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
  • Lau SL; Diabetes and Transcription Factors Group, Garvan Institute of Medical Research (GIMR), Sydney, NSW 2010, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW 2052, Australia; Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, NSW 2145, Australia.
  • Gunton JE; Diabetes and Transcription Factors Group, Garvan Institute of Medical Research (GIMR), Sydney, NSW 2010, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW 2052, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW 2052, Australia; Department of Diabetes
  • Wahl GM; Gene Expression Laboratory, Salk Institute, La Jolla, CA 92037, USA.
  • Hunter T; Molecular and Cell Biology Laboratory, Salk Institute, La Jolla, CA 92037, USA.
  • Drebin JA; Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • O'Dwyer PJ; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
  • Liddle C; The Storr Liver Unit, Westmead Millennium Institute and University of Sydney, Westmead Hospital, Westmead, NSW 2145, Australia.
  • Tuveson DA; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
  • Downes M; Gene Expression Laboratory, Salk Institute, La Jolla, CA 92037, USA. Electronic address: downes@salk.edu.
  • Evans RM; Gene Expression Laboratory, Salk Institute, La Jolla, CA 92037, USA; Howard Hughes Medical Institute, Salk Institute, La Jolla, CA 92037, USA. Electronic address: evans@salk.edu.
Cell ; 159(1): 80-93, 2014 Sep 25.
Article en En | MEDLINE | ID: mdl-25259922
The poor clinical outcome in pancreatic ductal adenocarcinoma (PDA) is attributed to intrinsic chemoresistance and a growth-permissive tumor microenvironment. Conversion of quiescent to activated pancreatic stellate cells (PSCs) drives the severe stromal reaction that characterizes PDA. Here, we reveal that the vitamin D receptor (VDR) is expressed in stroma from human pancreatic tumors and that treatment with the VDR ligand calcipotriol markedly reduced markers of inflammation and fibrosis in pancreatitis and human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in induced stromal remodeling, increased intratumoral gemcitabine, reduced tumor volume, and a 57% increase in survival compared to chemotherapy alone. This work describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response and suggests vitamin D priming as an adjunct in PDA therapy. PAPERFLICK:
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Calcitriol / Adenocarcinoma / Receptores de Calcitriol / Carcinoma Ductal Pancreático / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Cell Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Calcitriol / Adenocarcinoma / Receptores de Calcitriol / Carcinoma Ductal Pancreático / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Cell Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos